RecruitingPhase 4NCT04715568

Secondhand Tobacco Smoke and Cardiovascular Disease

Occult Cardiovascular Disease With Chronic Exposure to Secondhand Tobacco Smoke


Sponsor

University of California, San Francisco

Enrollment

100 participants

Start Date

Mar 30, 2021

Study Type

INTERVENTIONAL

Conditions

Summary

This is a double-blind randomized placebo-controlled crossover clinical trial of efficacy and safety of an FDA-approved angiotensin receptor blocker (losartan) to improve cardiopulmonary outcomes in individuals with pre-Chronic Obstructive Pulmonary Disease (COPD) due to prolonged exposure to secondhand tobacco smoke.


Eligibility

Min Age: 40 Years

Plain Language Summary

Simplified for easier understanding

This study examines how long-term exposure to secondhand tobacco smoke affects the heart and blood vessels — and whether a blood pressure medication can help protect against damage. It focuses on people who were heavily exposed at work before smoking bans were in place. **You may be eligible if:** - You are 40 years of age or older - You have a history of at least 5 years of occupational secondhand smoke exposure (e.g., as a flight attendant before airline smoking bans, or a casino worker before smoke-free policies) - You have never smoked, or you smoked very little (less than 1 pack-year total) and not at all in the past 20 years **You may NOT be eligible if:** - You currently take an ACE inhibitor or ARB blood pressure medication - You have known heart disease, kidney disease, severe lung disease, or significant vascular disease - You are pregnant or breastfeeding - You have very low blood pressure - Your BMI is below 15 or above 40 - You currently use NSAIDs (like ibuprofen) daily Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGLosartan

50 mg tablets taken orally

DRUGPlacebo

Tablets taken orally


Locations(1)

San Francisco Veterans' Affairs Medical Center

San Francisco, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04715568


Related Trials